Business
Bionano Genomics Announces a Record Number of Optical Genome Mapping Presentations Scheduled to Appear at the Annual Cancer Genomics Consortium Meeting from August 1st - 4th, 2021
SAN DIEGO, July 27, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced a record number of optical genome mapping (OGM)
About this update from Bionano Genomics, Inc.
[{"type":"text","content":"SAN DIEGO, July 27, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced a record number of optical genome mapping (OGM) presentations scheduled to appear at the annual Cancer Genomics Consortium (CGC) meeting being held from August 1 - 4, 2021. Across this four-day event, the meeting features 10 presentations by Bionano’s Saphyr® customers highlighting the benefits of OGM for clinical research applications in solid tumor analysis, hematological malignancies, products of conception, prenatal and postnatal constitutional genetics. In 2020, more than 500 participants from around the globe attended the CGC’s virtual meeting and attendance for this year’s four-day event is anticipated to be even higher. The 10 upcoming presentations featuring Saphyr-generated OGM data are listed below along with the associated application areas: OGM Application AreaPresenterAffiliationPresentation Title Solid Tumor AnalysisDr. Miriam BornhorstChildren's National HospitalOptical genome mapping reveals novel structural variants in pediatric high grade gliomas. Dr. Nikhil SahajpalAugusta UniversityClinical utility and feasibility of adopting optical genome mapping for chromosomal characterization of solid tumors. Hematological MalignanciesDr. Rashmi Kanagal-ShamannaMD Anderson Cancer CenterOptical genome mapping for chromosomal structural variants analysis in hematological malignancies. Dr. Gordana RacaChildren's Hospital Los AngelesComplementarity of RNA sequencing and optical genome mapping in detection of rare fusions in pediatric B-ALL. Dr. Victoria StinnettThe Johns Hopkins UniversityAdoption of optical genome mapping in clinical cancer cytogenetic laboratory: A stepwise approach. Dr. Guilin TangUT MD Anderson Cancer CenterOptical Genome Mapping Reveals Genomic Complexity and Detects Novel Genetic Abnormalities in T-Lymphoblastic Leukemia. Dr. Jia-Chi WangCity of Hope National Medical CenterIntegrative cytogenomics studies using optical genome mapping in two cases with chronic lymphocytic leukemia. Prenatal GeneticsNikhil SahajpalAugusta UniversityNext-generation cytogenetics: Proposal for a cost-effective approach for comprehensive testing of prenatal cases. Products of ConceptionDr. Nikhil SahajpalAugusta UniversityOptical genome mapping and SNP microarray: integrated workflow for optimizing analysis of products of conc...